Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (NASDAQ:TTNP)

1.70
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
1.30
Today|||52-Week Range
4.80
-57.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues10.5M3.6M1.7M15.1M
 
 
 
 
 
Depreciation And Amortization107.0K353.0K358.0K377.0K
 
 
 
 
 
 
Operating ExpensesGross Income--3.3M----
 
 
General Expenses11.3M6.8M8.1M10.3M
 
 
 
 
 
Research And Development8.3M4.1M4.7M6.1M
 
 
 
 
 
Total Operating Expenses11.4M7.1M8.4M10.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-891.0K-3.5M-6.8M4.3M
 
 
 
 
 
Extraordinary Credit12.6M1.1M0.00825.0K
 
 
 
 
Extraordinary Charge0.000.00-4.5M0.00
 
 
Interest Expense On Debt1.6M--0.000.00
 
 
Other Expenses-467.0K-11.0K-8.0K-70.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.7M-2.4M-11.3M5.1M
 
 
 
 
 
Net Income9.7M-2.4M-11.3M5.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.9M17.1M20.1M20.7M
 
 
 
 
 
Shares To Calculate EPS Diluted15.0M17.1M20.1M21.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.55-$0.22-$0.56$0.20
 
 
 
 
 
EPS Diluted$0.55-$0.22-$0.56$0.20